Company · CIK 0001761612 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
BICYCLE THERAPEUTICS PLC · BCYC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 SForm 4 → | Jul 7, 5:00 pm EDT | Jennifer Scott PerryChief Operating Officer | 1,412 | $4.29 | $6,054 | 91,052 | −1.53% | 10b5-1 |
| Jul 2, 2026 SForm 4 → | Jul 7, 5:00 pm EDT | Michael SkynnerCHIEF SCIENTIFIC OFFICER | 2,391 | $4.28 | $10,231 | 157,171 | −1.50% | |
| Jul 2, 2026 SForm 4 → | Jul 7, 5:00 pm EDT | Kevin LeeCHIEF EXECUTIVE OFFICER, Director | 7,642 | $4.28 | $32,701 | 603,671 | −1.25% | |
| Jul 2, 2026 SForm 4 → | Jul 7, 5:00 pm EDT | Michael Charles Ferguson HannayCHIEF PROD & SUPPLY CHAIN OFF | 1,761 | $4.28 | $7,530 | 94,375 | −1.83% | |
| Jul 2, 2026 SForm 4 → | Jul 7, 5:00 pm EDT | Travis Alvin ThompsonChief Financial Officer | 923 | $4.27 | $3,945 | 64,441 | −1.41% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 AForm 4 → | Jul 17, 4:15 pm EDT | Travis Alvin ThompsonChief Financial Officer | 60,000 | — | — | 60,000 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 4:15 pm EDT | Michael Charles Ferguson HannayCHIEF PROD & SUPPLY CHAIN OFF | 60,000 | — | — | 60,000 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 4:15 pm EDT | Michael SkynnerCHIEF SCIENTIFIC OFFICER | 60,000 | — | — | 60,000 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 4:15 pm EDT | Jennifer Scott PerryChief Operating Officer | 60,000 | — | — | 60,000 | — |